| Pyroptosis: a new frontier in cancer Y Fang, S Tian, Y Pan, W Li, Q Wang, Y Tang, T Yu, X Wu, Y Shi, P Ma, ... Biomedicine & Pharmacotherapy 121, 109595, 2020 | 863 | 2020 |
| Targeting FTO suppresses cancer stem cell maintenance and immune evasion R Su, L Dong, Y Li, M Gao, L Han, M Wunderlich, X Deng, H Li, Y Huang, ... Cancer cell 38 (1), 79-96. e11, 2020 | 591 | 2020 |
| Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression K Lu, W Li, X Liu, M Sun, M Zhang, W Wu, W Xie, Y Hou BMC cancer 13, 1-11, 2013 | 501 | 2013 |
| The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients ME Kennedy, AW Stamford, X Chen, K Cox, JN Cumming, MF Dockendorf, ... Science translational medicine 8 (363), 363ra150-363ra150, 2016 | 482 | 2016 |
| RNA demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia C Shen, Y Sheng, AC Zhu, S Robinson, X Jiang, L Dong, H Chen, R Su, ... Cell stem cell 27 (1), 64-80. e9, 2020 | 326 | 2020 |
| Multiple functions of m6A RNA methylation in cancer Y Pan, P Ma, Y Liu, W Li, Y Shu Journal of hematology & oncology 11, 1-11, 2018 | 298 | 2018 |
| Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor … YL Wu, Y Cheng, J Zhou, S Lu, Y Zhang, J Zhao, DW Kim, RA Soo, ... The Lancet Respiratory Medicine 8 (11), 1132-1143, 2020 | 231 | 2020 |
| Peptide SMIM30 promotes HCC development by inducing SRC/YES1 membrane anchoring and MAPK pathway activation Y Pang, Z Liu, H Han, B Wang, W Li, C Mao, S Liu Journal of hepatology 73 (5), 1155-1169, 2020 | 173 | 2020 |
| Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells W Li, M Sun, C Zang, P Ma, J He, M Zhang, Z Huang, Y Ding, Y Shu Cell death & disease 7 (5), e2225-e2225, 2016 | 173 | 2016 |
| PIWI proteins and PIWI-interacting RNA: emerging roles in cancer YN Han, Y Li, SQ Xia, YY Zhang, JH Zheng, W Li Cellular Physiology and Biochemistry 44 (1), 1-20, 2018 | 160 | 2018 |
| PIWI-interacting RNA-54265 is oncogenic and a potential therapeutic target in colorectal adenocarcinoma D Mai, P Ding, L Tan, J Zhang, Z Pan, R Bai, C Li, M Li, Y Zhou, W Tan, ... Theranostics 8 (19), 5213, 2018 | 146 | 2018 |
| MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer Y Yasumizu, H Rajabi, C Jin, T Hata, S Pitroda, MD Long, M Hagiwara, ... Nature communications 11 (1), 338, 2020 | 134 | 2020 |
| RETRACTED: The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB M Sun, F Nie, C Zang, Y Wang, J Hou, C Wei, W Li, X He, K Lu Molecular Therapy 25 (3), 739-751, 2017 | 129 | 2017 |
| Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor … T Xu, W Wang, P Ma, Y Shuai, K Zhao, Y Wang, W Li, R Xia, W Chen, ... Oncogene 37 (36), 5020-5036, 2018 | 126 | 2018 |
| Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a WEI Li, MIN Liu, YF Xu, Y Feng, JP Che, GC Wang, JH Zheng Oncology reports 31 (1), 117-124, 2014 | 124 | 2014 |
| ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma W Mao, K Wang, B Xu, H Zhang, S Sun, Q Hu, L Zhang, C Liu, S Chen, ... Molecular Cancer 20 (1), 142, 2021 | 106 | 2021 |
| The biogenesis and functions of piRNAs in human diseases X Wu, Y Pan, Y Fang, J Zhang, M Xie, F Yang, T Yu, P Ma, W Li, Y Shu Molecular Therapy Nucleic Acids 21, 108-120, 2020 | 105 | 2020 |
| Circular RNAs: A novel type of biomarker and genetic tools in cancer YN Han, SQ Xia, YY Zhang, JH Zheng, W Li Oncotarget 8 (38), 64551, 2017 | 100 | 2017 |
| Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer C Zang, F Nie, Q Wang, M Sun, W Li, J He, M Zhang, K Lu Oncotarget 7 (10), 11696, 2016 | 100 | 2016 |
| Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis Y Yu, H Wang, A Yan, H Wang, X Li, J Liu, W Li BMC cancer 18, 1-9, 2018 | 99 | 2018 |